Axon Enterprise (AXON) is transitioning from a SaaS+device vendor to a public-sector digital infrastructure provider, altering its financial profile and valuation dynamics. AXON's strong recurring ...

SCOTTSDALE, Ariz., Feb. 10, 2026 /PRNewswire/ -- Axon (Nasdaq: AXON), the global public safety technology leader, today announced that it will report fourth quarter 2025 financial results after the ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often ...

Axon Enterprise Inc’s stock has reached a new 52-week low, closing at $469.23. This marks a significant downturn for the company, which has seen its stock price decline by 28.55% over the past year.

Axon Enterprise, Inc. (NASDAQ:AXON) is one of the stocks Jim Cramer shared his opinion on. A caller asked about Cramer’s thoughts on the stock, and he remarked: You know, I saw the body camera story ...

Investing.com -- Axon Enterprise (NASDAQ:AXON) stock rose 4% after Department of Homeland Security Secretary Kristi Noem announced that federal agents will be equipped with body cameras in Minneapolis ...

The Chautauqua County Sheriff’s Office has announced a new partnership Wednesday with AXON to deploy its Community Request integration with Ring smart camera devices. This partnership allows the ...

A US Army Stryker performs a demonstration for the service taking down unmanned aircraft systems. (Leonardo DRS) Leonardo DRS has teamed up with Israel-based Axon Vision to develop integrated, ...

SAN FRANCISCO, CA, February 4, 2026 (EZ Newswire) -- Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, ...

The Chautauqua County Sheriff’s Office has announced a new partnership Wednesday with AXON to deploy its Community Request integration with Ring smart camera devices. This partnership allows the ...

Axon Neuroscience’s active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer’s disease phase 2 clinical trial (supported by a USD ...

Axon stock has tumbled more than 30% in little over a week, and all the evidence indicates that the maker of Tasers, body cameras, drones and software for law enforcement has been victimized by Wall ...